News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

Kromek Group "taking growth momentum" into second half

Kromek Group PLC

Kromek Group PLC (AIM:KMK) CEO Arnab Basu speaks to Proactive's Thomas Warner after publishing interim results that revealed revenue growth of more than 40%. Basu explains what's currently driving growth for the business and looks ahead to where he expects growth to come from in the future. He says that Kromek is "taking growth momentum" into the second half of its financial year. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

February 01, 2023 07:44 AM Eastern Standard Time

Video
Article thumbnail News Release

BiVictriX Therapeutics reports "really exciting" BCX001 data

BiVictriX Therapeutics PLC

BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) founder and CEO Tiffany Thorn speaks to Proactive's Thomas Warner after reporting positive results from a preclinical study of lead molecule BVX001, that she describes as "really exciting." Thorn explains the significance of the results and reveals how the business intends to move forward with the molecule having now established its "highly favourable" safety profile. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

February 01, 2023 07:33 AM Eastern Standard Time

Video
Article thumbnail News Release

Voyager Life rewards programme will help integrate online and high street outlets

Voyager Life PLC

Voyager Life PLC (AQSE:VOY) chief executive Nick Tulloch speaks to Proactive's Thomas Warner after announcing the launch of a new loyalty programme. He explains the reasons for introducing the scheme, highlighting the need to integrate Voyager's online and high street offerings. He also gives an update on the facility in Poland that the business acquired at the beginning of the year. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

February 01, 2023 07:25 AM Eastern Standard Time

Video
Article thumbnail News Release

Proactive's John Savin publishes fresh research note on Oxford Cannabinoid Technologies

Oxford Cannabinoid Technologies Holdings PLC

Proactive research analyst John Savin speaks to Thomas Warner after publishing a new report on Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF), in which he looks ahead to what investors can expect from the business on the clinical side during 2023. Savin gives the highlights from the report and discusses the company's financial position. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

February 01, 2023 06:42 AM Eastern Standard Time

Video
Article thumbnail News Release

Digital Addiction is Affecting Adolescent Brain Development, Mental Health Experts Warn

The Chicago School of Professional Psychology

Is your child addicted to social media? New research shows that social media could be reprogramming children’s brains—and psychologists warn parents that they need to pay closer attention. “Once a habit like constantly checking social media is formed, it’s difficult for adolescents to self-regulate, so parents may need to step in,” said Dr. Michele Nealon, Psy.D., President of The Chicago School of Professional Psychology. The new research focuses on overuse of screen time by adolescents in a three-year neurological study by the University of North Carolina. Results published this month in the Journal of the American Medical Association, show significant changes in the brains of 12 and 13-year-olds who reported habitually checking Facebook, Instagram and Snapchat. An earlier neurobiological study reported in the peer-reviewed journal PLOS One, showed another troubling effect: compulsive adolescent tweeters had widespread and significant decreases of functional connectivity in their brain’s cortico-striatal circuits. According to these studies, social media may alter neurodevelopment, significantly changing the ways in which the adolescent brain responds to its environment. Dr. Nealon said that since the brain undergoes significant structural and functional reorganization during adolescence, habitual checking of social media may further increase the already enhanced activity in the amygdala and insula, creating hyperactive neural responses to the anticipation of more “likes” and social media feedback. “The result is an ever-increasing need for digital social rewards and a reduction of ability to resist urges to check for feedback on social media platforms,” she explained. “This never-ending loop could interfere with school, athletics, friendships and other real world social interactions that are important for normal psychosocial development.” To counter addiction to digital media, Dr. Nealon has recommendations for parents: Limit screen time to under three hours a day, depending on your child’s age and activity level. Set parental controls on social media sites and monitor the content your child is viewing. Facilitate play dates and extracurricular activities to help develop other social skills About The Chicago School of Professional Psychology: Integrating theory with hands-on experience, The Chicago School of Professional Psychology provides education rooted in a commitment to innovation, service, and community for thousands of diverse students across the United States and globally. Founded in 1979, the nonprofit, regionally accredited university now features campuses in iconic locations across the country (Chicago, Southern California, Washington, D.C., New Orleans, Dallas) and online. To spark positive change in the world where it matters most, The Chicago School has continued to expand its educational offerings beyond the field of psychology to offer more than 30 degrees and certificates in the professional fields of health services, education, counseling, business, and more. Through its engaged professional model of education, commitment to diversity and inclusion, and an extensive network of domestic and international professional partnerships, The Chicago School’s students receive real-world training opportunities that reflect their future careers. The Chicago School is proud to be a part of TCS Education System, a nonprofit, integrated system of colleges and universities that works collaboratively to advance student success and community impact. To learn more, visit www.thechicagoschool.edu. Contact Details Vivien Hao +1 323-893-4743 vhao@thechicagoschool.edu

January 31, 2023 11:11 AM Pacific Standard Time

Article thumbnail News Release

Galexxy’s Wellbeing Farms Expands Smart Vending Kiosk Distribution to Texas

GALEXXY HLDGS INC.

McapMediaWire -- Galexxy Holdings Inc., (“Galexxy” or “Company”) (OTC: GXXY ) is pleased to announce that its 100% owned subsidiary, Wellbeing Farms LLC, (“Wellbeing,” or “WBF”) has executed its second strategic commercial supply and lease agreement with Delta 8 LLC (Delta) and its associated company, uVending LLC (uVending). Delta is developing the market in Texas for the sale and supply of its proprietary D88 products which are being manufactured by Wellbeing under an exclusive white label supply agreement. Delta will generate its D88 product sales utilizing customized, attractively branded Smart Vending Kiosks supplied by its Associate, uVending LLC., which are purchased under a blanket leasing agreement from Wellbeing Farms. Wellbeing’s customized Smart Kiosks are very distinctive, featuring glass fronted, backlit product displays to maximize product appeal and are equipped with patented ID-Age verification capability in order to comply with Texas state law. Based on their initial estimates, Delta is planning to install over six hundred D88 Smart Kiosks in the next 2 years which could potentially generate approximately $3,500,000 per month in D88 wholesale product purchases from Wellbeing. Michael Biagi, Wellbeing’s CEO stated that; “We are excited by the huge marketing potential of generating recurring product revenue through the placement of our Smart Kiosks by strategic partners who pay us to lease the kiosks to earn a share of the sales revenue”. He further stated that “We’re not limited to our current product range and can readily adapt Kiosk inventory to satisfy market needs.” Headquartered in Newport Beach, California with manufacturing facilities in Murietta, California, Galexxy’s shares are publicly traded on the OTC Markets (OTC: GXXY). Galexxy entered the rapidly developing markets for premium natural plant-based consumer health supplement products in April 2021 and completed its acquisition of Wellbeing Farms LLC., on August 4, 2022 and purchased 69% of ABC Wholesale Products LLC., on August 12, 2022. Galexxy Holdings Inc. Iain Saul E: Iain@galexxyholdings.com M: (801) 243 9570 Forward-Looking Information This press release contains “forward-looking information” and “forward-looking statements” (collectively, “statements”). All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this press release. www.wellbeingfarms.com https://twitter.com/GXXYHoldings www.delta88.vip www.uvending.vip Contact Details Galexxy Holdings Iain Saul +1 801-243-9570 Iain@galexxyholdings.com Company Website http://www.wellbeingfarms.com/

January 31, 2023 09:00 AM Eastern Standard Time

Article thumbnail News Release

Valeo Pharma announces company has filed new drug submission with Health Canada for sabizabulin

Valeo Pharma Inc.

Valeo Pharma chief executive Steve Saviuk joined Steve Darling from Proactive to share news the company has been told by Health Canada they have accepted for review Veru’s New Drug Submission (NDS-CV) for sabizabulin for COVID-19. Saviuk told Proactive Sabizabulin is an antiviral and anti-inflammatory agent being developed for the treatment of hospitalized moderate to severe COVID-19 adult patients at high risk for acute respiratory distress syndrome and death. The company will now wait to hear back from Health Canada. Contact Details Proactive Investors Stephen Gunnion +1 604-688-8158 na-editorial@proactiveinvestors.com

January 30, 2023 11:59 AM Eastern Standard Time

Video
Article thumbnail News Release

2023 Trends in New Drug Development

Syntekabio, Inc.

Syntekabio (KOSDAQ:226330.KQ)(226330:KS), a global AI drug discovery and development company, will participate in a special webinar hosted by the New York Health Forum (NYHF) on the latest drug discovery and development trends. What is at the core of transforming a once lengthy process full of complexity and uncertainties? Advancements in new technologies, including artificial intelligence (AI), Covid-19 and drug pricing legislation have disrupted drug discovery and development in the global biopharma industry. Syntekabio is leading this industry-wide transformation with its latest invention STB CLOUD, which can give clinical-stage pharmaceutical companies with limited drug discovery capability an ideal one-stop solution for fully automatic drug discovery.  In this webinar, renowned industry experts and leaders, along with Syntekabio’s Principal Scientist Hyun Joo, will address how the industry can continue innovation amid challenges and opportunities under the current economic conditions and discuss the best strategies forward. Details of the event are as follows: WHAT: NYHF Special Webinar III WHEN: Tuesday, Jan 31, 2023, 11:00 AM – 12:00 PM ET WHERE: Online via Zoom WHO: Taewan Kim, PhD, Professor, Columbia University; Kern Chang, PhD, Scientific Integrator/Associate Director, Janssen R&D; Hyun Joo, PhD, Principal Scientist/Director, Syntekabio; and John Duguid, PhD, Managing Director, Auctus Capital. The panel will be moderated by Joseph McMenamin, MD, JD, EVP, W Medical Strategy Group. NOTE: The webinar requires registration. It is free and open to the public. Register here to attend. A Q&A will follow the discussion. SyntekaBio is a global artificial intelligence (AI) and big data-based drug discovery and development company, headquartered in South Korea since 2009, with its U.S. operations bringing innovative technologies and science to create transformative medicines worldwide that are compliant with international standards to cure diseases and improve people's lives. Find out more about DeepMatcher®, NEO-ARS™, NGS-ARS™ and PGM-ARS™ at www.syntekabio.com. Contact Details Syntekabio USA | WMSG Sabina Lee +1 201-408-5342 wgroup@wmedical.org Company Website https://www.syntekabio.com/eng

January 30, 2023 10:00 AM Eastern Standard Time

Article thumbnail News Release

Vitaquest International Joins Council for Responsible Nutrition as Voting Member

Vitaquest

Vitaquest International, an industry-leading product development and commercialization partner in nutraceuticals and functional foods announced today that it has been accepted as a Voting Member at the Council for Responsible Nutrition (CRN) (Washington, DC). The 50-year-old CRN is a leading standards-promoting and advocacy association representing producers of dietary supplements, functional foods and health-promoting ingredients. According to Patrick Brueggman, Chief Executive Officer of Vitaquest, the move to join CRN reinforces recognition by the company of the impact and value the trade association has on advancing the scientific, quality and ethical standards of the nutraceuticals and functional foods industries. “The Council for Responsible Nutrition is a leader in focusing attention and supporting the issues that are critical to the advancement of our industry. Over their 50-year history, they have advocated for best practices in clinical science, manufacturing, marketing, quality control and safety,” he said. “We are delighted to become a voting member of CRN as we share its commitment to advancing all these best practices and to building trust with consumers as we provide finished products that support their health. We’re looking forward to engaging with other member companies of CRN and adding Vitaquest’s voice to a dialogue that looks to move our industry ahead,” he said. Brueggman has been appointed to the Council for Responsible Nutrition Board of Directors. Manufacturing Quality Supplements and Functional Foods for Over 45 years Vitaquest has been delivering innovation in consumer products since 1977. Over the last 45-plus years the company has established itself as one of the premier product development and manufacturing companies in the nutraceutical and functional foods business. It has grown as a result of successful collaborations with customers, its continual investment in the facilities and capabilities needed to support customers, and the company’s ability to anticipate the requirements of their markets. This is a full-service offering that includes formulation assistance, manufacturing, packaging, warehousing and fulfillment. Today, the company produces more than 4,000 custom formulas each year, serving more than 500 brands in 40 countries. On the quality front, Vitaquest offers its TotalQ™ Commitment to Quality, an initiative that draws on the company's activities in a broad range of functions and disciplines including raw material sourcing, ingredient integrity testing, product design, internal QA systems and final product Assurance. The company also offers VQ Solutions, a turnkey warehousing and fulfillment option for customers that starts from our manufacturing floor and ends at their customer’s location – getting products faster to market, reducing shipping costs and providing storage in a fully-certified storage facility. Says Brueggman, “At Vitaquest, we like to say that we can help our customers deliver what’s next in the health and well-being market. We feel that CRN has their eye on the future of our industry and we look forward to working closely with them to improve what comes next”. “The Council for Responsible Nutrition is a leader in focusing attention and supporting the issues that are critical to the advancement of our industry. Over their 50-year history, they have advocated for best practices in clinical science, manufacturing, marketing, quality control and safety. We are delighted to become a voting member of CRN as we share its commitment to advancing all these best practices and to building trust with consumers as we provide finished products that support their health." -- Patrick Brueggman, CEO of Vitaquest. About Vitaquest International Headquartered in West Caldwell, NJ USA, Vitaquest International is an industry-leading development and commercialization partner for consumer products featuring a broad array of innovative solutions in nutraceutical and functional foods. A leader in the design and development of new, standards-based quality initiatives, a comprehensive commitment to quality – called TotalQ™ – is at the core of Vitaquest as a company. With over 45 years of history, Vitaquest has the market insight, global reach and scale of operations to support emerging and existing consumer brands from the idea to the store shelf – with flawless execution in every phase. Contact Details Resource Advantage Dan Green dgreen@resourceadvantage.com

January 30, 2023 09:00 AM Eastern Standard Time

Image
1 ... 157158159160161 ... 295